The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The global NGS-based RNA-seq market was valued at US$ 1534.4 million in 2023 and is anticipated to reach US$ 3354.2 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-seq, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-seq.
Report Scope
The NGS-based RNA-seq market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGS-based RNA-seq market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS-based RNA-seq companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Illumina
- Thermo Fisher Scientific
- Pacific Biosciences Of California
- Qaigen
- F. Hoffmann-La Roche
- Agilent Technologies
- Oxford Nanopore Technologies
- Perkinelmer
- Eurofins Scientific
- Gatc Biotech
- Macrogen
Segment by Type
- High-Throughput Sequencing
- Third-Generation Sequencing Technology
Segment by Application
- Hospitals and Clinics
- Biopharma Companies
- Government Agencies
- Academic and Research Organizations
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-seq companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-seq Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 High-Throughput Sequencing
1.2.3 Third-Generation Sequencing Technology
1.3 Market by Application
1.3.1 Global NGS-based RNA-seq Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-seq Market Perspective (2019-2030)
2.2 NGS-based RNA-seq Growth Trends by Region
2.2.1 Global NGS-based RNA-seq Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NGS-based RNA-seq Historic Market Size by Region (2019-2024)
2.2.3 NGS-based RNA-seq Forecasted Market Size by Region (2025-2030)
2.3 NGS-based RNA-seq Market Dynamics
2.3.1 NGS-based RNA-seq Industry Trends
2.3.2 NGS-based RNA-seq Market Drivers
2.3.3 NGS-based RNA-seq Market Challenges
2.3.4 NGS-based RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-seq Players by Revenue
3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2019-2024)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-seq Revenue
3.4 Global NGS-based RNA-seq Market Concentration Ratio
3.4.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2023
3.5 NGS-based RNA-seq Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-seq Product Solution and Service
3.7 Date of Enter into NGS-based RNA-seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-seq Breakdown Data by Type
4.1 Global NGS-based RNA-seq Historic Market Size by Type (2019-2024)
4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2025-2030)
5 NGS-based RNA-seq Breakdown Data by Application
5.1 Global NGS-based RNA-seq Historic Market Size by Application (2019-2024)
5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NGS-based RNA-seq Market Size (2019-2030)
6.2 North America NGS-based RNA-seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NGS-based RNA-seq Market Size by Country (2019-2024)
6.4 North America NGS-based RNA-seq Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-seq Market Size (2019-2030)
7.2 Europe NGS-based RNA-seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NGS-based RNA-seq Market Size by Country (2019-2024)
7.4 Europe NGS-based RNA-seq Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-seq Market Size (2019-2030)
8.2 Asia-Pacific NGS-based RNA-seq Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NGS-based RNA-seq Market Size by Region (2019-2024)
8.4 Asia-Pacific NGS-based RNA-seq Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-seq Market Size (2019-2030)
9.2 Latin America NGS-based RNA-seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NGS-based RNA-seq Market Size by Country (2019-2024)
9.4 Latin America NGS-based RNA-seq Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-seq Market Size (2019-2030)
10.2 Middle East & Africa NGS-based RNA-seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NGS-based RNA-seq Market Size by Country (2019-2024)
10.4 Middle East & Africa NGS-based RNA-seq Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-seq Introduction
11.1.4 Illumina Revenue in NGS-based RNA-seq Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction
11.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Detail
11.3.2 Pacific Biosciences Of California Business Overview
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction
11.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2019-2024)
11.3.5 Pacific Biosciences Of California Recent Development
11.4 Qaigen
11.4.1 Qaigen Company Detail
11.4.2 Qaigen Business Overview
11.4.3 Qaigen NGS-based RNA-seq Introduction
11.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2019-2024)
11.4.5 Qaigen Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction
11.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies NGS-based RNA-seq Introduction
11.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Detail
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction
11.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2019-2024)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Detail
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer NGS-based RNA-seq Introduction
11.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2019-2024)
11.8.5 Perkinelmer Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Detail
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific NGS-based RNA-seq Introduction
11.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2019-2024)
11.9.5 Eurofins Scientific Recent Development
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Detail
11.10.2 Gatc Biotech Business Overview
11.10.3 Gatc Biotech NGS-based RNA-seq Introduction
11.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2019-2024)
11.10.5 Gatc Biotech Recent Development
11.11 Macrogen
11.11.1 Macrogen Company Detail
11.11.2 Macrogen Business Overview
11.11.3 Macrogen NGS-based RNA-seq Introduction
11.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2019-2024)
11.11.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
